| Literature DB >> 15549532 |
Abstract
In this paper we review new treatment options for migraine prevention. Because we focus on new drugs, some of the data we present herein were acquired in well design double blind, controlled studies, while the efficacy of other medication is supported only by open, uncontrolled trials (noted in the text wherever appropriate).Entities:
Mesh:
Substances:
Year: 2004 PMID: 15549532 DOI: 10.1007/s10072-004-0281-9
Source DB: PubMed Journal: Neurol Sci ISSN: 1590-1874 Impact factor: 3.307